Fund comparison · from official SEC filings
IBB vs LABU: how much do they overlap?
iShares Biotechnology ETF and Direxion Daily S&P Biotech Bull 3X Shares
Holdings overlap29%of assets, by weight Shared positions116of 253 / 154 holdings IBB expense ratio0.44%net, per year LABU expense ratio0.93%net, per year Shared holdings
V
VRTXVERTEX PHARMACEUTICALS INC
6.77%
0.76%
G
GILDGILEAD SCIENCES INC
6.64%
0.79%
A
AMGNAMGEN INC
6.63%
0.81%
R
REGNREGENERON PHARMACEUTICALS
5.03%
0.80%
A
ALNYALNYLAM PHARMACEUTICALS INC
5.02%
0.85%
I
INSMINSMED INC
2.61%
0.86%
N
NTRANATERA INC
1.87%
0.92%
B
BIIBBIOGEN INC
1.80%
0.87%
U
UTHRUNITED THERAPEUTICS CORP
1.61%
0.92%
1
1JKAPELLIS PHARMACEUTICALS INC
0.21%
1.44%
I
INCYINCYTE CORP
1.43%
0.89%
R
RVMDREVOLUTION MEDICINES INC
0.66%
1.27%
T
TVTXTRAVERE THERAPEUTICS INC
0.18%
1.25%
N
NBIXNEUROCRINE BIOSCIENCES INC
1.19%
0.89%
A
ARWRARROWHEAD PHARMACEUTICALS IN
0.39%
1.11%
T
TWSTTWIST BIOSCIENCE CORP
0.14%
1.10%
S
SMMTSUMMIT THERAPEUTICS INC
0.20%
1.09%
A
ALKSALKERMES PLC
0.42%
1.07%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.81%
1.06%
B
BEAMBEAM THERAPEUTICS INC
0.19%
1.02%
A
APGEAPOGEE THERAPEUTICS INC
0.13%
0.98%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.24%
0.95%
P
PRAXPRAXIS PRECISION MEDICINES I
0.09%
0.95%
E
EXELEXELIXIS INC
0.94%
0.94%
Only in IBB
B
BISXXBCF INSTITUTIONAL-SL AGNCY
11.65%
I
IQVIQVIA HOLDINGS INC
2.81%
A
ARGXARGENX SE - ADR
2.78%
M
MTDMETTLER-TOLEDO INTERNATIONAL
2.20%
O
ONCBEONE MEDICINES LTD-ADR
1.86%
W
WATWATERS CORP
1.56%
I
ILMNILLUMINA INC
1.24%
G
GMABGENMAB A/S -SP ADR
1.22%
M
MEDPMEDPACE HOLDINGS INC
1.02%
T
TECHBIO-TECHNE CORP
0.75%
A
ASNDASCENDIS PHARMA A/S
0.74%
T
TEMTEMPUS AI INC-CL A
0.68%
C
CRLCHARLES RIVER LABORATORIES
0.67%
R
RGENREPLIGEN CORP
0.62%
2
2GHMERUS NV
0.56%
B
BNTXBIONTECH SE-ADR
0.55%
V
VRNAVERONA PHARMA PLC - ADR
0.52%
?
—Avidity Biosciences, Inc.
0.44%
A
AXSMAXSOME THERAPEUTICS INC
0.44%
L
LEGNLEGEND BIOTECH CORP-ADR
0.36%
C
CRNXCRINETICS PHARMACEUTICALS IN
0.32%
A
ACLXARCELLX INC
0.30%
A
AKROAKERO THERAPEUTICS INC
0.29%
B
BRKRBRUKER CORP
0.29%
Only in LABU
?
—DREYFUS GOVERNMENT CASH MANAGE
7.43%
?
—GOLDMAN SACHS LIQ ES FD A
1.71%
T
TGTXTG THERAPEUTICS INC
1.06%
C
CELCCELCUITY INC
0.92%
6
6XCSOLENO THERAPEUTICS INC
0.82%
A
ABBVABBVIE INC
0.82%
V
VKTXVIKING THERAPEUTICS INC
0.77%
I
IMNMIMMUNOME INC
0.70%
?
—Catalyst Pharmaceuticals Inc.
0.66%
K
KODKODIAK SCIENCES INC
0.61%
D
DNTHDIANTHUS THERAPEUTICS INC
0.54%
A
ARDXARDELYX INC
0.50%
C
CLDXCELLDEX THERAPEUTICS INC
0.42%
C
CAPRCAPRICOR THERAPEUTICS INC
0.41%
V
VRDNVIRIDIAN THERAPEUTICS INC
0.37%
P
PVLAPALVELLA THERAPEUTICS INC
0.37%
S
SLSSELLAS LIFE SCIENCES GROUP I
0.24%
C
CTMXCYTOMX THERAPEUTICS INC
0.20%
Z
ZBIOZENAS BIOPHARMA INC
0.18%
S
SIONSIONNA THERAPEUTICS INC
0.17%
B
BCAXBICARA THERAPEUTICS INC
0.16%
P
PURRHYPERLIQUID STRATEGIES
0.16%
V
VORVOR BIOPHARMA INC
0.14%
Hold IBB and LABU together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →Other comparisons you might like
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.